Allianz’s 9M14 earnings of MYR225m was in line and met 76% of our FY14F forecasts, buoyed by AGIC’s double-digit earned premium growth and underwriting margin of 16% (above industry’s 13%), ALIM’s strong investment performance and higher renewal premium. We upgrade to BUY with an unchanged SOP TP of MYR13.50 (13% upside). Valuations appear attractive again due to the recent retracement.
Profit (+18% YoY growth) in line. Profits were supported by general insurance’s (GI) 17% net earned premium growth and 19% underwriting (UW) profit growth from its subsidiary Allianz General Insurance (AGIC), and favourable claims ratio from investment-linked business recorded from its life insurance (LI) unit, Allianz Life Insurance Malaysia (ALIM).
GI UW margins stable. AGIC recorded a 17% rise in net premium despite an 8% growth on gross premium, due to the group’s higher retention strategy (we estimate YTD retention ratio was 69%, vs 9M13’s 64%). The combined (claims + expense) ratio was relatively unchanged at 86% vs 9M13, demonstrating the group’s consistent track record to manage its margins, albeit normalised from a multi-year low of 80% in 1Q14. This is in line with our 86-87% assumption. AGIC’s motor premium exposure is relatively unchanged at 60% of total portfolio.Investment grew 12% along with asset growth, with yields at 3.8%.
LI performance. ALIM charted a strong 20% growth in gross written premium (GWP), mainly due to higher renewal premium that offsets the flat growth in annualised new business premiums (ANP) that was affected by the softening of traditional business. ALIM breached the 7,000 barrier with its agency force now standing at 7,088 agents, vs 6,918 in 1Q14 and 6,532 in 3Q14 – but still a long way to its 10,000target by FY15. Following the successful sale of HSBC bancassurance products since 4Q13, bancassurance contributed 15% (from 3% two years ago) to ANP channel mix. Agency investment-linked (IL) business recorded 26% in ANP growth and now accounts for 77% of agency ANP vs traditional. Investment yields surged to 6.1% due to fair value gains.
Upgrade to BUY with an unchanged SOP TP at MYR13.50, based on 16x FY15F GI profits and 1.2x FY15F LI embedded value of MYR1.1bn, as the share price retracement by 5% in the past three months offers a buying opportunity. We believe the fundamentals remain unchanged given consistent management’s track record. We continue to like its strategies to solidify its market position upon 2016’s detariffication environment. We retain our earnings forecasts pending information from its analyst briefing today.
Source: RHB
Chart | Stock Name | Last | Change | Volume |
---|
Created by kiasutrader | Jun 14, 2016
Created by kiasutrader | May 05, 2016